145 related articles for article (PubMed ID: 22430044)
1. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
Papierska L; Rabijewski M; Kasperlik-Załuska A; Zgliczyński W
Adv Med Sci; 2012 Jun; 57(1):51-7. PubMed ID: 22430044
[TBL] [Abstract][Full Text] [Related]
2. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
Gordon CM; Grace E; Emans SJ; Feldman HA; Goodman E; Becker KA; Rosen CJ; Gundberg CM; LeBoff MS
J Clin Endocrinol Metab; 2002 Nov; 87(11):4935-41. PubMed ID: 12414853
[TBL] [Abstract][Full Text] [Related]
4. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR
Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
6. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
Cauza E; Etemad M; Winkler F; Hanusch-Enserer U; Partsch G; Noske H; Dunky A
J Clin Pharm Ther; 2004 Oct; 29(5):431-6. PubMed ID: 15482386
[TBL] [Abstract][Full Text] [Related]
7. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
Koetz KR; Ventz M; Diederich S; Quinkler M
J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
[TBL] [Abstract][Full Text] [Related]
9. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
Jankowski CM; Gozansky WS; Kittelson JM; Van Pelt RE; Schwartz RS; Kohrt WM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
[TBL] [Abstract][Full Text] [Related]
10. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U; Teichmann J; Müller-Ladner U; Strunk J
Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
[TBL] [Abstract][Full Text] [Related]
11. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.
von Mühlen D; Laughlin GA; Kritz-Silverstein D; Bergstrom J; Bettencourt R
Osteoporos Int; 2008 May; 19(5):699-707. PubMed ID: 18084691
[TBL] [Abstract][Full Text] [Related]
12. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
13. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
Labrie F; Diamond P; Cusan L; Gomez JL; Bélanger A; Candas B
J Clin Endocrinol Metab; 1997 Oct; 82(10):3498-505. PubMed ID: 9329392
[TBL] [Abstract][Full Text] [Related]
14. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men.
Villareal DT; Holloszy JO; Kohrt WM
Clin Endocrinol (Oxf); 2000 Nov; 53(5):561-8. PubMed ID: 11106916
[TBL] [Abstract][Full Text] [Related]
15. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
[TBL] [Abstract][Full Text] [Related]
16. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.
Luo S; Labrie C; Bélanger A; Labrie F
Endocrinology; 1997 Aug; 138(8):3387-94. PubMed ID: 9231792
[TBL] [Abstract][Full Text] [Related]
17. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C
Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826
[TBL] [Abstract][Full Text] [Related]
18. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
Jankowski CM; Gozansky WS; Schwartz RS; Dahl DJ; Kittelson JM; Scott SM; Van Pelt RE; Kohrt WM
J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials.
Jankowski CM; Wolfe P; Schmiege SJ; Nair KS; Khosla S; Jensen M; von Muhlen D; Laughlin GA; Kritz-Silverstein D; Bergstrom J; Bettencourt R; Weiss EP; Villareal DT; Kohrt WM
Clin Endocrinol (Oxf); 2019 Feb; 90(2):293-300. PubMed ID: 30421439
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone.
Weiss EP; Shah K; Fontana L; Lambert CP; Holloszy JO; Villareal DT
Am J Clin Nutr; 2009 May; 89(5):1459-67. PubMed ID: 19321570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
